Respiratory muscle dysfunction in long-COVID patients.

Area of Science:

• Pulmonology
• Infectious Diseases
• Rehabilitation Medicine

Background:

• Long COVID, characterized by persistent symptoms beyond 4 weeks post-infection, affects many individuals.
• Fatigue, exertional intolerance, and dyspnea are common Long COVID sequelae, irrespective of initial disease severity.
• The underlying mechanisms of these persistent symptoms require further investigation.

Purpose of the Study:

• To investigate the prevalence of respiratory muscle dysfunction in persistently symptomatic Long COVID patients.
• To test the hypothesis that respiratory muscle dysfunction contributes to self-reported exercise intolerance in Long COVID.
• To identify potential biomarkers for Long COVID-related exercise intolerance.

Main Methods:

• A cross-sectional pilot study involving 67 patients (mild-to-moderate and moderate-to-critical convalescent).
• Measurements included neuroventilatory activity (P0.1), inspiratory muscle strength (PImax), and respiratory muscle strain (P0.1/PImax).
• Standard pulmonary function tests, blood gas analysis, 6-minute walk tests, and functional questionnaires were also utilized.

Main Results:

• 88% of symptomatic patients exhibited pathological respiratory muscle strain (P0.1/PImax).
• Reduced inspiratory muscle strength (PImax) was observed in both hospitalized (mean reduction) and non-hospitalized (65%) patients.
• Pathologically increased neuroventilatory drive (P0.1) was prevalent and associated with exercise-induced deoxygenation and reduced functional status.

Conclusions:

• Respiratory muscle dysfunction is a significant and novel aspect of Long COVID sequelae.
• Systematic respiratory muscle testing should be incorporated into the diagnostic workup for persistent Long COVID symptoms.
• These findings highlight a potential therapeutic target for improving exercise tolerance in Long COVID patients.